IL6 and COVID-19: During the period of COVID-19, HLJDD was also found to play a therapeutic role in COVID-19 through regulating multiple signaling pathways based on targeting genes such as IL6, IL10, MMP9, NOS2, VEGF, and TGFβ1 (Liu et al., 2021).